228 related articles for article (PubMed ID: 21285534)
21. [Evaluation of mass vaccination programmes: the experience of Hepatitis A in Catalonia].
Oviedo M; Muñoz P; Domínguez A; Carmona G; Batalla J; Borras E; Jansà JM
Rev Esp Salud Publica; 2009; 83(5):697-709. PubMed ID: 20111818
[TBL] [Abstract][Full Text] [Related]
22. A statistical model to estimate the impact of a hepatitis A vaccination programme.
Oviedo M; Pilar Muñoz M; Domínguez A; Borras E; Carmona G
Vaccine; 2008 Nov; 26(48):6157-64. PubMed ID: 18804511
[TBL] [Abstract][Full Text] [Related]
23. Impact of the single-dose universal mass vaccination strategy against hepatitis A in Brazil.
Souto FJD; de Brito WI; Fontes CJF
Vaccine; 2019 Feb; 37(6):771-775. PubMed ID: 30639462
[TBL] [Abstract][Full Text] [Related]
24. Impact of the national targeted Hepatitis A immunisation program in Australia: 2000-2014.
Thompson C; Dey A; Fearnley E; Polkinghorne B; Beard F
Vaccine; 2017 Jan; 35(1):170-176. PubMed ID: 27876203
[TBL] [Abstract][Full Text] [Related]
25. Long-term trends in hepatitis A incidence following the inclusion of Hepatitis A vaccine in the routine nationwide immunization program.
Chodick G; Heymann AD; Ashkenazi S; Kokia E; Shalev V
J Viral Hepat; 2008 Oct; 15 Suppl 2():62-5. PubMed ID: 18837837
[TBL] [Abstract][Full Text] [Related]
26. Time trends in pediatric hospitalizations for hepatitis A in Greece (1999-2013): Assessment of the impact of universal infant immunization in 2008.
Papaevangelou V; Alexopoulou Z; Hadjichristodoulou C; Kourlamba G; Katsioulis A; Theodoridou K; Spoulou V; Theodoridou M
Hum Vaccin Immunother; 2016 Jul; 12(7):1852-6. PubMed ID: 27141813
[TBL] [Abstract][Full Text] [Related]
27. Prospects for vaccination against hepatitis A and B in Catalonia (Spain).
Salleras L; Bruguera M; Buti M; Domíngez A
Vaccine; 2000 Feb; 18 Suppl 1():S80-2. PubMed ID: 10683557
[TBL] [Abstract][Full Text] [Related]
28. Modelling the decline and future of hepatitis A transmission in Australia.
Jayasundara D; Hui BB; Regan DG; Heywood AE; MacIntyre CR; Wood JG
J Viral Hepat; 2019 Jan; 26(1):199-207. PubMed ID: 30315680
[TBL] [Abstract][Full Text] [Related]
29. Control of a community-wide outbreak of hepatitis A by mass vaccination with inactivated hepatitis A vaccine.
Zamir C; Rishpon S; Zamir D; Leventhal A; Rimon N; Ben-Porath E
Eur J Clin Microbiol Infect Dis; 2001 Mar; 20(3):185-7. PubMed ID: 11347668
[TBL] [Abstract][Full Text] [Related]
30. Incidence of Hepatitis A in Argentina after vaccination.
Vacchino MN
J Viral Hepat; 2008 Oct; 15 Suppl 2():47-50. PubMed ID: 18837834
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of 10-year vaccination (2001-2010) on Hepatitis A in Tianjin, China.
Zhang ZL; Zhu XJ; Shan AL; Gao ZG; Zhang Y; Ding YX; Liu H; Wu WS; Liu Y; He HY; Xie XH; Xia WD; Li C; Xu WT; Li ZY; Lin HL; Fu WM
Hum Vaccin Immunother; 2014; 10(4):1008-12. PubMed ID: 24503599
[TBL] [Abstract][Full Text] [Related]
32. From hepatitis B to hepatitis A and B prevention: the Puglia (Italy) experience.
Germinario C; Lopalco PL; Chirona M; Da Villa G
Vaccine; 2000 Feb; 18 Suppl 1():S83-5. PubMed ID: 10683558
[TBL] [Abstract][Full Text] [Related]
33. Declining hepatitis A seroprevalence in adults in Catalonia (Spain): a population-based study.
Domínguez A; Bruguera M; Plans P; Espuñes J; Costa J; Plasencia A; Salleras L
BMC Infect Dis; 2007 Jul; 7():73. PubMed ID: 17610736
[TBL] [Abstract][Full Text] [Related]
34. Surveillance for acute viral hepatitis--United States, 2006.
Wasley A; Grytdal S; Gallagher K;
MMWR Surveill Summ; 2008 Mar; 57(2):1-24. PubMed ID: 18354374
[TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness analysis of universal childhood hepatitis A vaccination in Brazil: regional analyses according to the endemic context.
Sartori AM; de Soárez PC; Novaes HM; Amaku M; de Azevedo RS; Moreira RC; Pereira LM; Ximenes RA; Martelli CM
Vaccine; 2012 Dec; 30(52):7489-97. PubMed ID: 23107593
[TBL] [Abstract][Full Text] [Related]
36. Control of hepatitis A through routine vaccination of children.
Averhoff F; Shapiro CN; Bell BP; Hyams I; Burd L; Deladisma A; Simard EP; Nalin D; Kuter B; Ward C; Lundberg M; Smith N; Margolis HS
JAMA; 2001 Dec; 286(23):2968-73. PubMed ID: 11743837
[TBL] [Abstract][Full Text] [Related]
37. [Community outbreak of hepatitis A in a marginal population. Vaccination for its control and acceptance of the measure].
Arce Arnáez A; Cabello Ballesteros L; Iñigo Martínez J
Aten Primaria; 2007 Mar; 39(3):139-43. PubMed ID: 17386206
[TBL] [Abstract][Full Text] [Related]
38. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
[TBL] [Abstract][Full Text] [Related]
39. [Descriptive study of hepatitis outbreaks occurring in Catalonia (1999-2003)].
Llach-Berné M; Pañella H; Domínguez A; Caylà JA; Godoy P; Alvarez J; Sala R; Camps N;
Enferm Infecc Microbiol Clin; 2006; 24(7):431-6. PubMed ID: 16956531
[TBL] [Abstract][Full Text] [Related]
40. Universal vaccination of children against hepatitis A in Chile: a cost-effectiveness study.
Quezada A; Baron-Papillon F; Coudeville L; Maggi L
Rev Panam Salud Publica; 2008 May; 23(5):303-12. PubMed ID: 18510790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
